Literature DB >> 21378321

A new device for rapid isolation by size and characterization of rare circulating tumor cells.

Isabelle Desitter1, Bella S Guerrouahen, Naoual Benali-Furet, Janine Wechsler, Pasi A Jänne, Yanan Kuang, Masahiko Yanagita, Lilin Wang, Jillian A Berkowitz, Robert J Distel, Yvon E Cayre.   

Abstract

BACKGROUND: Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be used for all biological tests applying to the primary cells.
MATERIALS AND METHODS: The ScreenCell® devices are single-use and low-cost innovative devices that use a filter to isolate and sort tumor cells by size.
RESULTS: The ScreenCell® Cyto device is able to isolate rare, fixed, tumor cells, with a high recovery rate. Cells are well preserved morphologically. Immunocytochemistry and FISH assays can be performed directly on the filter. The ScreenCell® CC device allows isolation of live cells able to grow in culture. High quality genetic materials can be obtained directly from tumor cells isolated on the ScreenCell® MB device filter.
CONCLUSION: Due to their reduced size, versatility, and capacity to isolate CTCs within minutes, the ScreenCell® devices may be able to simplify and improve non-invasive access to tumor cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378321

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  119 in total

Review 1.  Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.

Authors:  Joshua M Jackson; Małgorzata A Witek; Joyce W Kamande; Steven A Soper
Journal:  Chem Soc Rev       Date:  2017-07-17       Impact factor: 54.564

Review 2.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

Review 3.  Circulating tumor cell enrichment based on physical properties.

Authors:  Ramdane A Harouaka; Merisa Nisic; Si-Yang Zheng
Journal:  J Lab Autom       Date:  2013-07-05

4.  Using circulating tumor cells to advance precision medicine in prostate cancer.

Authors:  Giuseppe Galletti; Daniel Worroll; David M Nanus; Paraskevi Giannakakou
Journal:  J Cancer Metastasis Treat       Date:  2017-09-27

5.  Circulating tumor cells: finding the needle in the haystack.

Authors:  Xiaoning Zhe; Michael L Cher; R Daniel Bonfil
Journal:  Am J Cancer Res       Date:  2011-06-01       Impact factor: 6.166

6.  Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives.

Authors:  Igor Cima; Chay Wen Yee; Florina S Iliescu; Wai Min Phyo; Kiat Hon Lim; Ciprian Iliescu; Min Han Tan
Journal:  Biomicrofluidics       Date:  2013-01-24       Impact factor: 2.800

7.  Highly selective biomechanical separation of cancer cells from leukocytes using microfluidic ratchets and hydrodynamic concentrator.

Authors:  Bill K Lin; Sarah M McFaul; Chao Jin; Peter C Black; Hongshen Ma
Journal:  Biomicrofluidics       Date:  2013-06-26       Impact factor: 2.800

Review 8.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

Review 9.  NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.

Authors:  Yu Jen Jan; Jie-Fu Chen; Yazhen Zhu; Yi-Tsung Lu; Szu Hao Chen; Howard Chung; Matthew Smalley; Yen-Wen Huang; Jiantong Dong; Li-Ching Chen; Hsiao-Hua Yu; James S Tomlinson; Shuang Hou; Vatche G Agopian; Edwin M Posadas; Hsian-Rong Tseng
Journal:  Adv Drug Deliv Rev       Date:  2018-03-15       Impact factor: 15.470

10.  Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?

Authors:  Noriyoshi Sawabata; Soichiro Funaki; Takeru Hyakutake; Yasushi Shintani; Ayako Fujiwara; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-03-07       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.